YU43010B - Process for obtaining new derivatives of 3-(1-piperidinylalkyl)-4h-pyrido /1,2a-/ pyrimidine-4-ones - Google Patents
Process for obtaining new derivatives of 3-(1-piperidinylalkyl)-4h-pyrido /1,2a-/ pyrimidine-4-onesInfo
- Publication number
- YU43010B YU43010B YU810/81A YU81081A YU43010B YU 43010 B YU43010 B YU 43010B YU 810/81 A YU810/81 A YU 810/81A YU 81081 A YU81081 A YU 81081A YU 43010 B YU43010 B YU 43010B
- Authority
- YU
- Yugoslavia
- Prior art keywords
- piperidinylalkyl
- pyrido
- pyrimidine
- ones
- obtaining new
- Prior art date
Links
- DNCYBUMDUBHIJZ-UHFFFAOYSA-N 1h-pyrimidin-6-one Chemical class O=C1C=CN=CN1 DNCYBUMDUBHIJZ-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/30—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/34—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13484580A | 1980-03-28 | 1980-03-28 | |
| US06/191,632 US4342870A (en) | 1980-03-28 | 1980-09-29 | Novel 3-(1-piperidinylalkyl)-4H-pyrido[1,2-a]pyrimidin-4-one derivatives |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| YU81081A YU81081A (en) | 1983-12-31 |
| YU43010B true YU43010B (en) | 1989-02-28 |
Family
ID=26832744
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| YU810/81A YU43010B (en) | 1980-03-28 | 1981-03-27 | Process for obtaining new derivatives of 3-(1-piperidinylalkyl)-4h-pyrido /1,2a-/ pyrimidine-4-ones |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US4342870A (cs) |
| EP (1) | EP0037265B1 (cs) |
| AU (1) | AU537700B2 (cs) |
| BG (1) | BG36199A3 (cs) |
| CA (1) | CA1163994A (cs) |
| CS (1) | CS256366B2 (cs) |
| DE (1) | DE3168433D1 (cs) |
| DK (1) | DK159390C (cs) |
| ES (1) | ES500814A0 (cs) |
| FI (1) | FI71737C (cs) |
| GR (1) | GR72488B (cs) |
| HU (1) | HU187329B (cs) |
| IE (1) | IE51319B1 (cs) |
| IL (1) | IL62494A (cs) |
| MA (1) | MA19107A1 (cs) |
| NO (1) | NO156752C (cs) |
| NZ (1) | NZ196522A (cs) |
| PH (1) | PH16530A (cs) |
| PT (1) | PT72740B (cs) |
| RO (1) | RO82508A (cs) |
| SU (1) | SU1068037A3 (cs) |
| YU (1) | YU43010B (cs) |
Families Citing this family (42)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4443451A (en) * | 1981-07-15 | 1984-04-17 | Janssen Pharmaceutica N.V. | Bicyclic pyrimidin-5-one derivatives |
| US4548938A (en) * | 1981-07-15 | 1985-10-22 | Janssen Pharmaceutica N.V. | 5-H-1,3,4-thiadiazolo[3,2-a]pyrimidin-5-one compounds |
| US4355037A (en) * | 1981-11-12 | 1982-10-19 | Hoechst-Roussel Pharmaceuticals | 3-(4-Piperidyl)-1,2-benzisoxales |
| US4485107A (en) * | 1982-11-01 | 1984-11-27 | Janssen Pharmaceutica N.V. | [[Bis(aryl)methylene]-1-piperidinyl]alkyl-pyrimidinones |
| US4581171A (en) * | 1983-07-27 | 1986-04-08 | Janssen Pharmaceutica, N.V. | [[Bis(aryl)methylene]-1-piperidinyl]alkyl-pyrimidinones useful for treating psychotropic disorders |
| US4888426A (en) * | 1983-11-30 | 1989-12-19 | Janssen Pharmaceutica N.V. | 1-(5-methyl-furan-2-ylmethyl)-N-(4-piperidinyl)imidazo [4,5-6]pyridine-2-amine |
| US4695569A (en) * | 1983-11-30 | 1987-09-22 | Janssen Pharmaceutica N.V. | Bicyclic heterocyclyl containing N-(bicyclic heterocyclyl)-4-piperidinamines |
| PH23995A (en) * | 1984-01-09 | 1990-02-09 | Janssen Pharmaceutica Nv | 4((bicycle heterocyclyl)-methyl and hetero)piperidines |
| US4548939A (en) * | 1984-10-01 | 1985-10-22 | Janssen Pharmaceutica N. V. | 1H-Indol-3-yl containing 1,3-dimethyl-1H-purine-2,6-diones |
| US4804663A (en) * | 1985-03-27 | 1989-02-14 | Janssen Pharmaceutica N.V. | 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles |
| ES2094718T3 (es) * | 1986-09-22 | 1997-02-01 | Janssen Pharmaceutica Nv | Antagonistas de la serotonine para el tratamiento de heridas. |
| IL90879A0 (en) * | 1988-09-02 | 1990-02-09 | Janssen Pharmaceutica Nv | 3-piperidinyl-indazole derivatives,their preparation and antihypertensive compositions containing them |
| CA2000786C (en) * | 1988-11-07 | 1999-01-26 | Cornelus G. M. Janssen | 3-piperidinyl-1,2-benzisoxazoles |
| US5153206A (en) * | 1988-12-02 | 1992-10-06 | Pfizer Inc. | Arylpiperidine derivatives |
| JPH04504263A (ja) * | 1989-03-23 | 1992-07-30 | マリンクロッド・インコーポレイテッド | 放射性沃素又は臭素標識ピペリジン化合物、並びに上記化合物の及び上記化合物を含む組成物の製法 |
| DE4138756A1 (de) * | 1991-11-26 | 1993-05-27 | Troponwerke Gmbh & Co Kg | Kombination mit neuroprotektiver wirkung |
| US5266571A (en) * | 1992-01-09 | 1993-11-30 | Amer Moh Samir | Treatment of hemorrhoids with 5-HT2 antagonists |
| AU669156B2 (en) * | 1992-02-13 | 1996-05-30 | Merrell Dow Pharmaceuticals Inc. | Piperidinyl thiacyclic derivatives |
| ES2159526T3 (es) * | 1992-07-13 | 2001-10-16 | Janssen Pharmaceutica Nv | Nuevos derivados de 4-(3-benzofuranil)piperidinilo y 4-(3-benzotienil)piperidinilo y composiciones farmaceuticas que los contienen. |
| JP3645906B2 (ja) * | 1993-11-19 | 2005-05-11 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | マイクロカプセル封入された３−ピペリジニル−置換１，２−ベンズイソオキサゾール類及び１，２−ベンズイソチアゾール類 |
| ES2085234B1 (es) * | 1994-02-24 | 1997-01-16 | Vita Invest Sa | Agente activo sobre el sistema nervioso central, procedimiento para su preparacion y composiciones farmaceuticas que lo contienen. |
| TW421649B (en) * | 1995-01-31 | 2001-02-11 | Janssen Pharmaceutica Nv | 4-(1H-indol-1yl)-1-piperidinyl derivatives |
| US5753664A (en) * | 1995-03-16 | 1998-05-19 | Takeda Chemical Industries, Ltd. | Heterocyclic compounds, their production and use |
| HRP20050424A2 (en) * | 2002-11-13 | 2006-08-31 | Synthon B.V. | Process for making risperidone and intermediates thereof |
| EP1615923A1 (en) * | 2003-04-22 | 2006-01-18 | Synthon B.V. | Risperidone monohydrochloride |
| EP3106166B1 (en) * | 2008-02-29 | 2020-12-02 | VM Therapeutics LLC | Compounds for treating pain syndrome and other disorders |
| CN119528903A (zh) | 2012-02-10 | 2025-02-28 | Ptc医疗公司 | 用于治疗脊髓性肌萎缩的化合物 |
| EA029155B1 (ru) | 2012-03-01 | 2018-02-28 | ПиТиСи ТЕРАПЬЮТИКС, ИНК. | Соединения для лечения спинальной мышечной атрофии |
| MX358514B (es) | 2012-03-23 | 2018-08-24 | Ptc Therapeutics Inc | Compuestos para tratar la atrofia muscular espinal. |
| US9724348B2 (en) | 2013-03-15 | 2017-08-08 | Vm Therapeutics Llc | Crystalline forms |
| WO2015105657A1 (en) | 2013-12-19 | 2015-07-16 | Ptc Therapeutics, Inc. | Methods for modulating the amount of rna transcripts |
| EP3310169B1 (en) | 2015-05-30 | 2023-05-17 | PTC Therapeutics, Inc. | Methods for modulating rna splicing |
| PT3386511T (pt) | 2015-12-10 | 2021-07-14 | Ptc Therapeutics Inc | Métodos para tratamento da doença de huntington |
| JP2019535789A (ja) | 2016-11-28 | 2019-12-12 | ピーティーシー セラピューティクス，インコーポレーテッド | Ｒｎａスプライシングを調節する方法 |
| EP4151627A1 (en) | 2017-06-05 | 2023-03-22 | PTC Therapeutics, Inc. | Compounds for treating huntington's disease |
| BR112019026508A2 (pt) | 2017-06-14 | 2020-07-14 | Ptc Therapeutics, Inc. | métodos para modificar o splicing do rna |
| WO2019005993A1 (en) | 2017-06-28 | 2019-01-03 | Ptc Therapeutics, Inc. | METHODS OF TREATING HUNTINGTON'S DISEASE |
| BR112019027717A2 (pt) | 2017-06-28 | 2020-07-28 | Ptc Therapeutics, Inc. | métodos para tratar a doença de huntington |
| EA202092001A1 (ru) | 2018-03-27 | 2021-01-29 | ПиТиСи ТЕРАПЬЮТИКС, ИНК. | Соединения для лечения болезни гентингтона |
| SMT202400286T1 (it) | 2018-06-27 | 2024-09-16 | Ptc Therapeutics Inc | Composti eterociclici ed eteroarilici per il trattamento della corea di huntington |
| JP7515415B2 (ja) | 2018-06-27 | 2024-07-12 | ピーティーシー セラピューティクス， インコーポレイテッド | ハンチントン病を処置するためのヘテロアリール化合物 |
| US11685746B2 (en) | 2018-06-27 | 2023-06-27 | Ptc Therapeutics, Inc. | Heteroaryl compounds for treating Huntington's disease |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3412094A (en) * | 1967-06-21 | 1968-11-19 | Searle & Co | 5-alkyl-2-amino-4-azido-6-phenylpyrimidines and congeners |
| US3960863A (en) * | 1974-06-25 | 1976-06-01 | Sankyo Company Limited | Pyrido[1,2-a]pyrimidinone derivatives |
| JPS5146497A (en) * | 1974-10-19 | 1976-04-20 | Masato Aiura | Hobuban |
| JPS525795A (en) * | 1975-06-28 | 1977-01-17 | Sankyo Co Ltd | Preparation of tetrahydro pyridopyrimidinone derivatives |
| HU173438B (hu) * | 1975-11-27 | 1979-05-28 | Chinoin Gyogyszer Es Vegyeszet | Sposob poluchenija novykh proizvodnykh 4-okso-1,6,7,8-/tetragidro-4h-pirido/1,2/pirimidina s zaderzhivajuhhejj vozgoranie aktivnot'ju i protivosvertivajuhhem effektom |
-
1980
- 1980-09-29 US US06/191,632 patent/US4342870A/en not_active Expired - Lifetime
-
1981
- 1981-03-03 GR GR64291A patent/GR72488B/el unknown
- 1981-03-04 CA CA000372258A patent/CA1163994A/en not_active Expired
- 1981-03-17 NZ NZ196522A patent/NZ196522A/en unknown
- 1981-03-17 AU AU68429/81A patent/AU537700B2/en not_active Ceased
- 1981-03-21 MA MA19313A patent/MA19107A1/fr unknown
- 1981-03-24 CS CS812134A patent/CS256366B2/cs unknown
- 1981-03-24 SU SU813261927A patent/SU1068037A3/ru active
- 1981-03-26 DK DK138281A patent/DK159390C/da not_active IP Right Cessation
- 1981-03-26 PH PH25429A patent/PH16530A/en unknown
- 1981-03-26 IL IL62494A patent/IL62494A/xx unknown
- 1981-03-26 PT PT72740A patent/PT72740B/pt not_active IP Right Cessation
- 1981-03-27 ES ES500814A patent/ES500814A0/es active Granted
- 1981-03-27 IE IE706/81A patent/IE51319B1/en not_active IP Right Cessation
- 1981-03-27 EP EP81301335A patent/EP0037265B1/en not_active Expired
- 1981-03-27 HU HU81783A patent/HU187329B/hu not_active IP Right Cessation
- 1981-03-27 NO NO811058A patent/NO156752C/no unknown
- 1981-03-27 YU YU810/81A patent/YU43010B/xx unknown
- 1981-03-27 DE DE8181301335T patent/DE3168433D1/de not_active Expired
- 1981-03-27 FI FI810956A patent/FI71737C/fi not_active IP Right Cessation
- 1981-03-27 BG BG051433A patent/BG36199A3/xx unknown
- 1981-03-28 RO RO81103848A patent/RO82508A/ro unknown
Also Published As
| Publication number | Publication date |
|---|---|
| RO82508B (ro) | 1983-08-30 |
| DK159390C (da) | 1991-03-04 |
| GR72488B (cs) | 1983-11-14 |
| SU1068037A3 (ru) | 1984-01-15 |
| RO82508A (ro) | 1983-09-26 |
| BG36199A3 (en) | 1984-09-14 |
| IE810706L (en) | 1981-09-28 |
| US4342870A (en) | 1982-08-03 |
| EP0037265B1 (en) | 1985-01-23 |
| NO156752B (no) | 1987-08-10 |
| CS256366B2 (en) | 1988-04-15 |
| DK159390B (da) | 1990-10-08 |
| HU187329B (en) | 1985-12-28 |
| PT72740A (en) | 1981-04-01 |
| DE3168433D1 (de) | 1985-03-07 |
| MA19107A1 (fr) | 1981-10-01 |
| NO811058L (no) | 1981-09-29 |
| DK138281A (da) | 1981-09-29 |
| PH16530A (en) | 1983-11-10 |
| FI71737B (fi) | 1986-10-31 |
| NZ196522A (en) | 1985-10-11 |
| FI810956L (fi) | 1981-09-29 |
| FI71737C (fi) | 1987-02-09 |
| IE51319B1 (en) | 1986-12-10 |
| ES8300763A1 (es) | 1982-11-01 |
| NO156752C (no) | 1987-11-18 |
| IL62494A (en) | 1984-08-31 |
| CA1163994A (en) | 1984-03-20 |
| PT72740B (en) | 1982-11-16 |
| IL62494A0 (en) | 1981-05-20 |
| YU81081A (en) | 1983-12-31 |
| AU6842981A (en) | 1981-10-01 |
| ES500814A0 (es) | 1982-11-01 |
| AU537700B2 (en) | 1984-07-05 |
| EP0037265A1 (en) | 1981-10-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| YU43010B (en) | Process for obtaining new derivatives of 3-(1-piperidinylalkyl)-4h-pyrido /1,2a-/ pyrimidine-4-ones | |
| RO83101B (ro) | Procedeu de preparare a unor derivati de nicotinamida | |
| HUT34741A (en) | Process for preparing new derivatives of 1-ethyl-2,6-dimethyl-8-hydroxy-polyhydro-naphthalene | |
| YU126281A (en) | Process for obtaining new pyridoxine derivatives | |
| PL232331A1 (en) | Method of obtaining new derivatives of 6a,10 n-trans-9-beta-amino-1-hydroxyocta-hydrobenzene/o/ quinoline | |
| PT73712A (en) | Process for the production of derivatives of 2-(2-benzofuranyl)ethanolamine | |
| YU42448B (en) | Process for obtaining derivative of 5,6,7,7a-tetrahydro-4h-thieno-(3,2-c)pyridinone-2- | |
| PL232330A1 (en) | Method of obtaining new derivatives of oxazolidinodione-2,4 | |
| GR64892B (en) | Method for the preparation of new derivatives of 1,3 diphenoxypropan-2-on | |
| YU44524B (en) | Process for obtaining derivatives of 3,4-dihydro-2h-benzopyrans | |
| PL241179A1 (en) | Process for preparing novel derivatives of 4a,9b-trans-hexahydro-1h-pyridoindole | |
| PL235949A1 (en) | Process for preparing derivatives of 2,3,4-trinor-1,5-inter-m-phenyleneprostacyclin | |
| PT72565A (en) | Process for the preparation of phenoxy-aminopropanol derivatives | |
| AU9141182A (en) | 9-(3-(3,5-cis-dimethylpiperazino)propyl)carbazole for treatment of anxiety | |
| NZ197563A (en) | 3-(1,2,4-triazinylthiomethyl)-3-cephem-1-sulphoxide derivatives | |
| HU182341B (en) | Process for preparing new substituted phenoxy-amino-propanol derivatives | |
| YU163779A (en) | Process for obtaining imidazolyl-ethoxy derivatives of pyrrazolo (3,4-b)-pyridine-5-methanol | |
| YU41953B (en) | Process for obtaining new derivatives of 1-xo-1h-thizolo (3,2-a) pyrimidine-2-carboxamides | |
| PH19848A (en) | Process for the preparation of 5,6,7,7a-tetrahydro-4-thieno (3,2-c)-pyridin-2-one derivatives | |
| PT73870A (en) | Process for the preparation of 11-dodecen-1-yl derivatives | |
| PT74114B (en) | Process for the preparation of 1,2-dihydro-5-(pyridinyl)-nico- tinamide derivatives | |
| YU41184B (en) | Process for obtaining 2-amino-or 2-thio-substituted derivatives of 4,5 dipheryl - oxazole | |
| DE3163891D1 (en) | Process for the preparation of vinylphosphoric-acid derivatives | |
| PL231451A1 (en) | Process for preparing derivatives of methylquinoxaline 1,4-dioxide | |
| PT75026B (en) | Process for the preparation of 1,2,3,4,4a,9b-hexahydro-4a-piperazinylmethyl 4-dibenzofuranone or -dibenzofuranol derivatives |